News
MMTZF
0.320
NaN%
--
Weekly Report: what happened at RLFTF last week (0810-0814)?
Weekly Report · 4d ago
MindMaze Therapeutics Taps Leading Neuroscientist John Krakauer to Steer U.S. Growth
TipRanks · 08/12 05:33
Weekly Report: what happened at RLFTF last week (0803-0807)?
Weekly Report · 08/10 09:58
MindMaze Streamlines to Core Neurology as Neuro.io Financing Advances
TipRanks · 08/10 05:34
Weekly Report: what happened at RLFTF last week (0727-0731)?
Weekly Report · 08/03 09:58
Weekly Report: what happened at RLFTF last week (0720-0724)?
Weekly Report · 07/27 10:01
Weekly Report: what happened at RLFTF last week (0713-0717)?
Weekly Report · 07/20 09:58
Weekly Report: what happened at RLFTF last week (0706-0710)?
Weekly Report · 07/13 10:00
MindMaze Backs Pitt Trial Combining Spinal Stimulation and High-Intensity Neurotherapy for Stroke Recovery
TipRanks · 07/09 05:33
Weekly Report: what happened at RLFTF last week (0629-0703)?
Weekly Report · 07/06 10:03
MindMaze Advances European At-Home Neurorehab Push with New Swiss and French Trials
TipRanks · 07/01 05:33
Weekly Report: what happened at RLFTF last week (0622-0626)?
Weekly Report · 06/29 09:59
MindMaze Shareholders Back Governance Moves but Reject Conditional Capital Increase
TipRanks · 06/25 11:03
Weekly Report: what happened at RLFTF last week (0615-0619)?
Weekly Report · 06/22 10:06
Weekly Report: what happened at RLFTF last week (0608-0612)?
Weekly Report · 06/15 10:07
Weekly Report: what happened at RLFTF last week (0601-0605)?
Weekly Report · 06/08 10:04
MindMaze Sets June AGM to Vote on Board Expansion and Capital Increase
TipRanks · 06/03 05:02
MindMaze Sheds Non-Core Assets to Sharpen Neurology Focus
TipRanks · 06/02 05:02
Weekly Report: what happened at RLFTF last week (0525-0529)?
Weekly Report · 06/01 10:07
MindMaze Raises CHF 8 Million from Neuro.io, Eyes AI Partnership and Potential Tie-Up
TipRanks · 05/26 05:03
More
Webull provides a variety of real-time MMTZF stock news. You can receive the latest news about Relief Hldg through multiple platforms. This information may help you make smarter investment decisions.
About MMTZF
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.